vanda pharmaceuticals inc
(VNDA:Consolidated Issue listed on NASDAQ Global Market)
Mihael H. Polymeropoulos M.D.
Founder, Chief Executive Officer, President and Director, Vanda Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 6 board members in 1 different organizations across 1 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. Mihael H. Polymeropoulos, M.D. founded Vanda Pharmaceuticals, Inc. in 2003 and has been its Chief Executive Officer and President since May, 2003. Dr. Polymeropoulos has also been the Chief Financial Officer at Vanda Pharmaceuticals, Inc. since August 6, 2010 and served as its Principal Accounting Officer since August 6, 2010. He served as Vice President and Head of the Pharmacogenetics Department at Novartis Pharmaceuticals Corporation (Maryland). He served as the ...
2200 Pennsylvania Avenue NWPhone: 202-734-3400
Washington, District Of Columbia 20037
Board Members Memberships*
Founder, Chief Executive Officer, President and Director
University of Patras
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|Christopher A. Viehbacher||Chief Executive Officer, Director and Member of Strategy Committee|
|Masayo Tada||Chief Executive Officer, President, Representative Director and Chairman of Risk Management Committee|
Sumitomo Dainippon Pharma Co., Ltd.
|Glenn A. Oclassen Sr.||Chairman of the Board, Chief Executive Officer and President|
Transcept Pharmaceuticals, Inc.
|$560.0K||Compensation as of Fiscal Year 2013.|